Two NEJM randomized trials in four months — SWiFT and TOWAR — both failed to show prehospital whole blood is superior to component therapy. Here's what the numbers actually say, what they don't, and what your program should do this week.

The May 2026 CoTCCC update expands tourniquet reposition and conversion to ASM and CLS tiers, pulls OTFC and IV fentanyl from first-line analgesia in favor of a suzetrigine-anchored CWMP, and ships the first standalone pediatric TCCC document. Here is what working tac medics — military and civilian — actually need to know.